Albaconazole
Albaconazole (development code UR-9825) is an experimental triazole antifungal.[1] It has potential broad-spectrum activity and exhibits inhibition of numerous CYP450 hepatic enzymes.
![]() | |
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.170.829 |
| Chemical and physical data | |
| Formula | C20H16ClF2N5O2 |
| Molar mass | 431.823146 g/mol g·mol−1 |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
| (verify) | |
It has also been studied as an antiprotozoal agent.[2]
References
- "Albaconazole". Adis Insight.
- Guedes, P. M. d. M.; Urbina, J. A.; De Lana, M.; Afonso, L. C. C.; Veloso, V. M.; Tafuri, W. L.; Machado-Coelho, G. L. L.; Chiari, E.; Bahia, M. T. (2004). "Activity of the New Triazole Derivative Albaconazole against Trypanosoma (Schizotrypanum) cruzi in Dog Hosts". Antimicrobial Agents and Chemotherapy. 48 (11): 4286–4292. doi:10.1128/AAC.48.11.4286-4292.2004. PMC 525424.
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.
